Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-05-31
1996-12-10
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514921, 536 21, A61K 31725, C08B 3710
Patent
active
055831214
ABSTRACT:
A method of treating hypovolemic shock and related shock syndromes by the administration of substantially non-anticoagulant heparinoids without the hemorrhaging problems generally associated with heparin; such syndromes include degradation of the microvascular structure, immune and gastrointestinal tract dysfunction, and multiple organ failure.
REFERENCES:
patent: 4847338 (1989-07-01), Lindhardt et al.
patent: 4916219 (1990-04-01), Linhardt et al.
patent: 4990502 (1991-02-01), Lormeau et al.
patent: 5034520 (1991-07-01), Lormeau et al.
Sharath et al., Immunopharmacology (1985) 9:73-80.
Singh et al., The Journal of Trauma (1993) 34:5:645-652.
Wang et al., American Journal of Physiology (1990) 28:645-650.
Waheed et al., The Journal of Trauma (1992) 32:4:420-426.
Wang et al., Journal of Surgical Research (1993) 54:499-506.
Chaudry et al., The American Journal of Surgery (1993) 165:2A:59S-67S .
Chaudry et al., Immunologic Aspects of Hemmorhage (1992) Chapter 4:35-40.
Cotran et al., Robbins Pathologic Basis of Disease (4th Edition) 114-120.
Singh et al. Presentation and discussion at the Fifty-Second Annual Session of the American Association for the Surgery of Trauma, Sep. 17-19, 1992, Louisville, KY, as described in J. Trauma May 1993, 34(5), 645-652.
Rana et al. J. Trauma 1992, 32(4), 420-426.
"Dorland's Pocket Medical Dictionary" W. B. Saunders Co., 1989, pp. 539-540.
Hobson II et al. Microcirc. Endoth. Lymphatics 1989, 5, 259-276.
Deitch Discussion of the Singh et al. presentation (L) at the Fifty-Second Annual Session of the American Association for the Surgery of Trauma, Sep. 17-19, 1992, Louisville, KY, as described in J. Trauma May 1993, 34(5), 645-652.
Chaudry, et al, "A Clinically Relevant Model of Hemorrhagic Shock and Resuscitation in the Rat", Cir. Shock (1989) 27 318.
Chaudry et al., "Rat and Mouse Models of Hypovolemic-Traumatic Shock," Pathophysiology of Shock, Sesis, and Organ Failure (1993) pp. 371-383.
Chaudry Irshad H.
Holme Kevin R.
Fonda Kathleen Kahler
Glycomed Incorporated
Michigan State University
Robinson Douglas W.
LandOfFree
Non-anticoagulant chemically modified heparinoids for treating h does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-anticoagulant chemically modified heparinoids for treating h, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-anticoagulant chemically modified heparinoids for treating h will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-424274